•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

AEGON ASSET MANAGEMENT UK Plc reduced its stake in Morgan Stanley (NYSE:MS) by 7.2% during the fourth quarter, according to the firm’s most recent SEC disclosure. The investor held 716,857 shares after selling 55,638 shares in the period. Morgan Stanley accounted for about 1.5% of AEGON ASSET MANAGEMENT UK Plc’s portfolio, making it the 12th largest holding. The position was valued at $127,270,000 at the end of the most recent reporting period.
Several other hedge funds and institutional investors also reported changes to their Morgan Stanley positions. Olistico Wealth LLC initiated a new position valued at approximately $27,000 in the fourth quarter. Lodestone Wealth Management LLC also started a new position valued at approximately $28,000, while Nvest Wealth Strategies Inc. initiated a new position valued at approximately $31,000.
Mowery & Schoenfeld Wealth Management LLC increased its holdings by 1,855.6% in the fourth quarter, bringing its total to 176 shares valued at $31,000 after purchasing an additional 167 shares. Greykasell Wealth Strategies Inc. raised its stake by 65.2% in the third quarter, ending with 185 shares valued at $29,000 after adding 73 shares. Overall, institutional investors and hedge funds own 84.19% of the company’s stock.
Insider trading disclosures included sales by Daniel A. Simkowitz and Andrew M. Saperstein. Simkowitz sold 32,968 shares on Friday, January 30th at an average price of $182.61, for total proceeds of $6,020,286.48. After the sale, he directly owned 357,342 shares valued at approximately $65,254,222.62, representing an 8.45% decrease in ownership.
Saperstein sold 51,668 shares on Thursday, April 16th at an average price of $188.59, generating $9,744,068.12. Following the transaction, he owned 282,142 shares valued at approximately $53,209,159.78, a 15.48% decrease in ownership. Over the last three months, insiders sold 110,444 shares worth $20,665,049. Corporate insiders own 0.17% of the stock.
Morgan Stanley opened at $188.13 on Friday. The company reported a debt-to-equity ratio of 3.39, a current ratio of 0.81, and a quick ratio of 0.81. Shares have a 50-day simple moving average of $170.25 and a 200-day simple moving average of $171.90. Morgan Stanley’s 1-year range is $112.03 to $194.59, and the company’s market capitalization is $297.50 billion. Valuation metrics include a P/E ratio of 17.04, a P/E/G ratio of 1.42, and a beta of 1.19.
Morgan Stanley last released earnings results on Wednesday, April 15th. The firm reported quarterly earnings of $3.43 per share, exceeding analysts’ consensus estimates of $3.02 by $0.41. Morgan Stanley’s return on equity was 17.89% and net margin was 14.65%. Revenue for the quarter was $20.58 billion, compared with a consensus estimate of $19.23 billion. In the prior-year quarter, the company posted $2.60 earnings per share. Revenue increased 16.0% year over year.
Analysts expect Morgan Stanley to post 11.8 earnings per share for the current year.
Morgan Stanley also declared a quarterly dividend to be paid on Friday, May 15th. Stockholders of record as of Thursday, April 30th will receive a dividend of $1.00 per share. The ex-dividend date is Thursday, April 30th. The dividend implies an annualized payout of $4.00 and a dividend yield of 2.1%, with a payout ratio of 36.23%.
Research firms updated their outlooks for Morgan Stanley. HSBC raised its target price from $153.00 to $177.00 and maintained a hold rating in a report on Friday, April 17th. Citizens Jmp restated a market perform rating on Thursday, April 16th. Argus increased its target price from $210.00 to $225.00 and upgraded the stock to a buy rating on Thursday, April 16th. Barclays raised its target price from $219.00 to $230.00 and assigned an overweight rating on Thursday, April 16th. Rothschild & Co Redburn increased its target price from $171.00 to $183.00 and kept a neutral rating in a report on Friday, April 17th.
Ten analysts rate the stock as Buy and thirteen rate it as Hold. Based on MarketBeat data, the consensus rating is Hold with a consensus price target of $201.89.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…